Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.215    0.00 (0.00%)
Bid:
0.18
Ask:
0.25
Spread: 0.07 (38.889%)
Market Cap: £1.13m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

Acquisition

30 Nov 2006 17:56

Expro International Group PLC30 November 2006 NOt for release, publication or distribution, in whole or in part, in, into orfrom the united states of america, canada, australia, japan or south africa 30 November 2006 Expro International Group PLC Acquisition of Power Well Services (the "PWS Acquisition") Expro International Group PLC (the "Company") today announces that it has agreedto release the vendors ("Vendors") of Power Well Services Inc, and Power WellHoldings Luxembourg S.A.R.L. ("PWS") from their lockup undertakings (enteredinto as part of the PWS Acquisition arrangements) to the extent required to inorder to enable them to sell up to 8,350,607 ordinary shares of 10p each in theCompany ("Expro Shares") through a proposed accelerated book-built placing (the"Placing") also announced today by JPMorgan Cazenove Limited (the "PlacingAnnouncement"). The Vendors are FR IX Offshore, L.P., Schmidt 2001 FamilyPartnership, Ltd and D&D Schmidt Family Partnership, Ltd and the 8,350,607 ExproShares were received by them as partial consideration under the PWS Acquisitionarrangements and represent in aggregate approximately 7.6% of the existingissued ordinary share capital of the Company. The Company notes from thePlacing Announcement that if all the 8,350,607 Expro Shares are sold, FR IXOffshore, L.P., and D&D Schmidt Family Partnership, Ltd will no longer holdExpro Shares and Schmidt 2001 Family Partnership, Ltd will hold 169,536 ExproShares representing approximately 0.15% of the of the existing issued ordinaryshare capital of the Company. As part of the arrangements to release the Vendors from the lockup undertakingsfor the purpose of the placing, the Company has agreed that if net cash proceedsfrom the sale of some or all of the 8,350,607 Expro Shares pursuant to thePlacing are: (a) equal to or in excess of US$67,450,000, then US$67,450,000 ofthe net cash proceeds will be retained within the escrow arrangements agreed atthe time of the PWS Acquisition and the request to obtain the Company's consentto the disposal of the Expro Shares in the lockup undertaking will cease; or (b) less that US$67,450,000, then Expro Shares, to the extent thatsuch shares are not sold in the placing, having a value equal to US$74,195,000will be retained within the escrow arrangements agreed at the time of the PWSAcquisition and the Company's consent to the disposal of such shares then heldby the Vendor's in the lockup undertakings will continue as originally agreed asregards the Expro Shares then held by the Vendors. This amends the original agreement to retain within the escrow arrangements on27 January 2007 (being 180 days after First Completion) Expro Shares of a valueequal to $74,195,000. Enquiries:Expro International Group PLC +44 1189 591 341Michael Speakman, Finance DirectorJohn McAlister, General CounselJPMorgan Cazenove Limited +44 20 7588 2828(Corporate broker to Expro)Barry Weir This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Mar 202312:00 pmRNSResult of EGM
27th Feb 20233:45 pmRNSSigning of Subscription Agreement and TVR
7th Feb 202311:45 amRNSPosting of Circular
6th Feb 202312:00 pmRNS£8.8 million Placing
6th Feb 20237:00 amRNSProposed Placing of New Ordinary Shares
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSENGAGE showcases first AI-powered virtual employee
18th Jan 20237:00 amRNSFY2022 Trading Update and Notice of Results
12th Dec 20222:05 pmRNSSecond Price Monitoring Extn
12th Dec 20222:00 pmRNSPrice Monitoring Extension
12th Dec 202211:05 amRNSSecond Price Monitoring Extn
12th Dec 202211:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSTrading Update
21st Nov 20227:00 amRNSCommercial reseller agreement signed with Lenovo
7th Nov 20227:00 amRNSLaunch of ENGAGE Link & Investor Presentation
28th Sep 202211:00 amRNSENGAGE XR to collaborate with Lenovo
21st Sep 20222:09 pmRNSHolding(s) in Company
13th Sep 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSInvestor Presentation
2nd Aug 20227:00 amRNSPre-Close Trading Update and Notice of Results
18th Jul 202211:00 amRNSDirectors’ Disclosure
23rd Jun 20227:00 amRNSENGAGE & METAVERSE UPDATE
16th Jun 202211:58 amRNSResult of AGM
16th May 20224:11 pmRNSNotice of AGM, Posting of Annual Report & Accounts
7th Apr 20224:40 pmRNSSecond Price Monitoring Extn
7th Apr 20224:35 pmRNSPrice Monitoring Extension
7th Apr 20227:00 amRNSEngage and Victory XR to Launch 10 Metaversities
28th Mar 20227:00 amRNSNew Senior Appointments to help drive US Growth
8th Mar 20227:01 amRNSFinal Results
4th Mar 202211:30 amRNSAIM Rule 17 Schedule 2(g) Update
16th Feb 20227:00 amRNSNotice of Results & Investor Presentation
31st Jan 20227:00 amRNSPre-Close Trading Update & Directorate Change
23rd Nov 20217:00 amRNSDirectorate Changes
12th Nov 20217:00 amRNSENGAGE Update & Investor Presentation
5th Nov 202110:24 amRNSExercise of Options
1st Jul 20081:02 pmRNSDirector Dealings
1st Jul 200811:16 amRNSScheme Effective
30th Jun 20085:52 pmRNSHolding(s) in Company
30th Jun 20083:03 pmRNSRule 8.3- Expro International
30th Jun 20082:19 pmBUSRule 8.3 - Expro International
30th Jun 200812:52 pmRNSEPT Disclosure - Expro Intern
30th Jun 200812:42 pmRNSEPT Disclosure - Expro Intl G
30th Jun 200812:37 pmRNSEPT Disclosure - Expro Intern
30th Jun 200812:11 pmRNSRule 8.3- Expro International
30th Jun 200811:16 amRNSHolding(s) in Company
30th Jun 200811:03 amRNSScheme of arrangement
27th Jun 20085:01 pmRNSRule 2.10 Announcement
27th Jun 20085:00 pmRNSSuspension - Expro Internatio
27th Jun 20084:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.